Clinical trials are an important way to improve treatment for people with cancer. While most are continuing during the COVID-19 pandemic, the period of time that clinical trials are available and recruiting may change quickly. If you would like to get involved in a clinical trial, speak to your treatment team or the health service where the clinical trial is being undertaken, to confirm it is open and appropriate for you. For cancer information and support, call Cancer Council's experienced cancer nurses on 13 11 20 Monday to Friday from 9am-5pm.

SIOPEN LINES : European Low and Intermediate Risk Neuroblastoma Protocol

Male or<br/>FemaleGender Male or

RecruitingStatus Recruiting


ThreePhase Three

0-18Age 0-18

Brain and Spinal<br/>CancersCancer LocationBrain and Spinal

Radiotherapy,Surgical,Systemic therapy | Brain and spinal cordNeuroblastoma

Trial Overview Read MoreRead more

This Phase III trial is managing the treatment (which may involve chemotherapy, radiotherapy and/or surgery) of people with low and intermediate risk patients with neuroblastoma.

This trial is treating patients with neuroblastoma.

This is a systemic therapy, radiotherapy and surgical trial.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

European Low and Intermediate Risk Neuroblastoma Protocol

Other Non-Commercial Sponsor

Instituto de Investigacion Sanitaria La Fe


This trial groups together into a single protocol the treatment of all patients with "non high risk" neuroblastoma, with stratification into two groups: low risk and intermediate risk. Treatment may include chemotherapy, surgery and radiotherapy, or a combination of these treatments, depending on individual cases.

Recruiting Hospitals Read MoreRead more

Monash Children's Cancer Centre
Dr Narmatha Kuru

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.